Directors' Dealings

25 January 2011

Imperial Innovations Group plc

Directors' Dealings

In accordance with Rule 17 of the AIM Rules, Imperial Innovations Group plc (the "Company" or "Imperial Innovations") announces the following changes in interests in ordinary shares of 3 and 1/33p each in the Company ("Ordinary Shares").

Imperial Innovations was notified on 20 January by Martin Knight, Chairman, that on 20 January 2011 he sold 1,515 Ordinary Shares in Imperial Innovations at a price of 400 pence per share. This transaction decreases the total direct and indirect voting right interest of Martin Knight in Ordinary Shares of Imperial Innovations from 110,503 to 108,988 Ordinary Shares, the latter being approximately 0.174% of the issued voting share capital of Imperial Innovations admitted to trading on AIM and 0.109% of the total issued voting share capital.

Imperial Innovations was notified on 24 January 2011 by RBC cees Trustee Limited, the trustee of the Group's Employee Benefit Trust (the Trustee) that on 20 January 2011 the Trustee sold at a price of 400 pence per share 21,652 Ordinary Shares in Imperial Innovations from a total of 370,249 Ordinary Shares which the Trustee had notified Martin Knight that it would consider making available to benefit him.

Imperial Innovations was notified on 20 January 2011 by Susan Searle, Chief Executive Officer, that on 20 January 2011 she sold 4,360 Ordinary Shares in Imperial Innovations at a price of 400 pence per share. This transaction decreases the total direct and indirect voting right interest of Susan Searle in Ordinary Shares of Imperial Innovations from 96,172 to 91,812 Ordinary Shares, the latter being approximately 0.147% of the issued voting share capital of Imperial Innovations admitted to trading on AIM and 0.092% of the total issued voting share capital.

Imperial Innovations was notified on 24 January 2011 by RBC cees Trustee Limited, the trustee of the Group's Employee Benefit Trust (the Trustee) that on 20 January 2011 the Trustee sold at a price of 400 pence per share 7,431 Ordinary Shares in Imperial Innovations from a total of 450,780 Ordinary Shares which the Trustee had notified Susan Searle that it would consider making available to benefit her.

Imperial Innovations was notified on 20 January 2011 by Julian Smith, Chief Financial and Operations Officer, that on 20 January 2011 he sold 3,425 Ordinary Shares in Imperial Innovations at a price of 400 pence per share. This transaction decreases the total direct and indirect voting right interest of Julian Smith in Ordinary Shares of Imperial Innovations from 61,504 to 58,079 Ordinary Shares, the latter being approximately 0.093% of the issued voting share capital of Imperial Innovations admitted to trading on AIM and 0.058% of the total issued voting share capital.

Imperial Innovations was notified 24 January 2011 by RBC cees Trustee Limited, the trustee of the Group's Employee Benefit Trust (the Trustee) that on 20 January 2011 the Trustee sold at a price of 400 pence per share 1,261 Ordinary Shares in Imperial Innovations from a total of 185,388 Ordinary Shares which the Trustee had notified Julian Smith that it would consider making available to benefit him.

Imperial Innovations was notified on 20 January 2011 by Russ Cummings, Chief Investment Officer, that on 20 January 2011 he sold 396 Ordinary Shares in Imperial Innovations at a price of 400 pence per share. This transaction decreases the total direct and indirect voting right interest of Russ Cummings in Ordinary Shares of Imperial Innovations from 2,577 to 2,181 Ordinary Shares, the latter being approximately 0.003% of the issued voting share capital of Imperial Innovations admitted to trading on AIM and 0.002% of the total issued voting share capital.

Imperial Innovations was notified 24 January 2011 by RBC cees Trustee Limited, the trustee of the Group's Employee Benefit Trust (the Trustee) that on 20 January 2011 the Trustee sold at a price of 400 pence per share 1,754 Ordinary Shares in Imperial Innovations from a total of 114,274 Ordinary Shares which the Trustee had notified Russ Cummings that it would consider making available to benefit him.

Imperial Innovations was notified on 24 January 2011 that Dr Paul Atherton, Non-Executive Director, had acquired 13,750 New Ordinary Shares pursuant to the 2 for 3 Rights Issue. This transaction increases the total direct and indirect voting interest right of Dr Paul Atherton in Ordinary Shares of Imperial Innovations from 20,625 to 34,375 Ordinary Shares, the latter being approximately 0.055% of the issued voting share capital of Imperial Innovations admitted to trading on AIM and 0.034% of the total issued voting share capital.

Imperial Innovations was notified on 24 January 2011 that Dr David Allen, Non-Executive Director, had acquired 2,875 New Ordinary Shares pursuant to the 2 for 3 Rights Issue. This transaction increases the total direct and indirect voting interest right of Dr Paul Atherton in Ordinary Shares of Imperial Innovations from 4,313 to 7,188 Ordinary Shares, the latter being approximately 0.011% of the issued voting share capital of Imperial Innovations admitted to trading on AIM and 0.007% of the total issued voting share capital.

Enquiries: